A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Circle 1500

Circle 1500 benefits the Women’s Cancers Program at City of Hope.
Our annual membership dues supports innovative research in search of solutions to breast and gynecologic cancers. Each year we vote to fund one of several promising research projects.

How can I help?
  • Join Circle 1500
  • Attend quarterly meetings and events
  • Vote on proposed projects
  • Encourage friends to join
 
Membership Dues
Annual membership is $500 (fully tax-deductible) and includes:

  • Four meetings each year
  • Annual celebration highlighting
  • Circle 1500-funded research
  • Opportunities to learn about important women’s health issues
 
Want to do more?
Join the Founder’s Circle for $1,500 (fully tax-deductible), which also includes:
 
  • Invitation-only opportunities to interact with Women’s Cancers Program physicians and researchers

 
 
 
For more information or to join, contact Janet Morgan at 213-241-7250 or jmorgan@coh.org.
 

 
About City of Hope's Women's Cancers Program
City of Hope has a history of innovation — including the technology behind Herceptin, a breakthrough drug for breast cancer.
 
Today, the Women’s Cancers Program at City of Hope brings together experts across disciplines in dynamic collaborations. And special on-site drug manufacturing facilities enable City of Hope to translate discovery into treatment faster and more efficiently.
 
Some exciting areas of research in the Women’s Cancers Program:
  • Seeking new treatments that defeat disease with fewer and milder side effects
  • Developing medicines that target women’s cancers precisely
  • Studying superfoods like mushroom and blueberries as ways to prevent or treat women’s cancers
  • Examining which choices women can make to stop cancer before it ever starts

Photos

 
Circle 1500's January 2013 Breakfast Meeting: Sexuality After Cancer:
“Often a problem; seldom discussed”
 
An information meeting for Circle 1500 was held at City of Hope on September 19, 2013.  Guests and members met the leadership of the Women’s Cancers Program faculty, heard research updates from the Women’s Cancers Program, and had the opportunity to share their experiences with cancer.  Every woman knows someone who has dealt with breast or gynecologic cancer, and treatment and research advances at City of Hope provide promise for the future.  We welcome you to join our group and help to make a difference.
 
 
 
Events
 
Please join us for a lunch meeting on Thursday, July 17, 2014

Noon to 1:30 P.M.

WILSHIRE COUNTRY CLUB
301 N. Rossmore Ave., Los Angeles, CA 90004

EXERCISE AND CANCER PREVENTION IN WOMEN:
Reducing DNA Damage and Inflammation
JESSICA CLAGUE DEHART, PH.D., M.P.H

UPDATE ON THE STATUS OF FUNDED RESEARCH PROJECT
JOANNE MORTIMER, M.D.
Director of the Women’s Cancers Program at City of Hope

A special group photo to be taken at this event!
Please wear or bring white

R.S.V.P. to Janet Morgan at 213-241-7250
or jmorgan@coh.org

Circle 1500 members are encouraged to bring guests to the meeting.
 

Save the Date
New Member Meeting
Thursday, October 16, 2014
5 to 6:30 P.M.
JULIENNE FINE FOODS AND CELEBRATIONS
San Marino
 
 
City of Hope has earned the highest overall rating of four stars for fiscal responsibility from Charity Navigator, America's premier independent charity watchdog group, for the fifth straight year.
Subscribe to news by email
Sign up for news and updates from City of Hope by email.  View our privacy policy .
 
 
 
NEWS & UPDATES
  • Eleven years ago, lymphoma patient Christine Pechera began the long road toward a cancer-free life. She had been diagnosed with non-Hodgkin lymphoma and told by doctors elsewhere that her lifespan likely would be measured in months, not years. Refusing to give up, she came to City of Hope for a second opinion. ...
  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...
  • The well-known drug tamoxifen might not always be the best choice for premenopausal women who have undergone treatment for breast cancer and face a heightened risk of recurrence. A new study suggests that the aromatase inhibitor exemestane, or Aromasin, works slightly better than tamoxifen in preventing cancer ...
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. The cancer grows and spreads quickly, making it difficult to treat. Most patients with this diagnosis are not given much hope, but Hanchette’s i...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • News about the risks or benefits of widespread cancer screening seem to arrive daily – 3D mammography for breast cancer, CT scans for lung cancer, PSA tests for prostate cancer and now pelvic exams for some women’s cancers. Missing in the headlines is a reflection of how cancer detection is evolving. Today’s ca...
  • Adults with sickle cell disease soon may have a new treatment option: bone marrow transplants. Children with sickle cell disease have been treated successfully with transplantation of bone marrow, more officially known as hematopoietic stem cells, from other people. But the procedure has been less successful in...